Franco-Indian Pharmaceuticals Pvt., Ltd.
⚠️ Moderate Risk
FEI: 3002902183 • Mumbai, Maharashtra • INDIA
FEI Number
3002902183
Location
Mumbai, Maharashtra
Country
INDIAAddress
54 - B Mathuradas Vasanji Marg, , Mumbai, Maharashtra, India
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
FRNMFGREG
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.
DIRECTIONS
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 7/26/2019 | 61WAO04CLOTRIMAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 1/6/2015 | 61WBJ04CLOTRIMAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC) | Baltimore District Office (BLT-DO) | |
| 9/4/2014 | 56GDJ99ANTIFUNGAL N.E.C. | Division of Northeast Imports (DNEI) | |
| 6/6/2014 | 62GBO99ANTI-INFLAMMATORY N.E.C. | Division of Northeast Imports (DNEI) | |
| 11/17/2004 | 61PDY55METFORMIN HCL (ANTI-DIABETIC) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
Frequently Asked Questions
What is Franco-Indian Pharmaceuticals Pvt., Ltd.'s FDA import refusal history?
Franco-Indian Pharmaceuticals Pvt., Ltd. (FEI: 3002902183) has 5 FDA import refusal record(s) in our database, spanning from 11/17/2004 to 7/26/2019.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Franco-Indian Pharmaceuticals Pvt., Ltd.'s FEI number is 3002902183.
What types of violations has Franco-Indian Pharmaceuticals Pvt., Ltd. received?
Franco-Indian Pharmaceuticals Pvt., Ltd. has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Franco-Indian Pharmaceuticals Pvt., Ltd. come from?
All FDA import refusal data for Franco-Indian Pharmaceuticals Pvt., Ltd. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.